Alcidion Group Limited (ALC.AX)
AUD 0.08
(-2.56%)
AUD 0.08
(-2.56%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -4.49 Million AUD | -214.85% |
| 2023 | -1.42 Million AUD | -391.48% |
| 2022 | -1.58 Million AUD | 86.57% |
| 2021 | -474 Thousand AUD | 113.67% |
| 2020 | -3.77 Million AUD | -3374.75% |
| 2019 | -59.59 Thousand AUD | 97.24% |
| 2018 | -3.11 Million AUD | -3.68% |
| 2017 | -3.06 Million AUD | 14.71% |
| 2016 | -2.44 Million AUD | -524.13% |
| 2015 | -278.15 Thousand AUD | -51.69% |
| 2014 | -276.1 Thousand AUD | 86.27% |
| 2013 | -1.95 Million AUD | 38.67% |
| 2012 | -3.06 Million AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2.92 Million AUD | 0.0% |
| 2024 FY | - AUD | -130.41% |
| 2024 Q4 | -2.74 Million AUD | 0.0% |
| 2023 Q4 | -341 Thousand AUD | 0.0% |
| 2023 FY | - AUD | -391.48% |
| 2023 Q2 | -1.19 Million AUD | 0.0% |
| 2022 Q4 | 3.83 Million AUD | 0.0% |
| 2022 FY | - AUD | 86.57% |
| 2022 Q2 | -3.3 Million AUD | 0.0% |
| 2021 Q4 | -4.85 Million AUD | 0.0% |
| 2021 FY | - AUD | 113.67% |
| 2021 Q2 | -888.58 Thousand AUD | 0.0% |
| 2020 Q2 | -1.7 Million AUD | 0.0% |
| 2020 Q4 | -1.04 Million AUD | 0.0% |
| 2020 FY | - AUD | -3374.75% |
| 2019 Q4 | 1.96 Million AUD | 0.0% |
| 2019 FY | - AUD | 97.24% |
| 2019 Q2 | -543.85 Thousand AUD | 0.0% |
| 2018 Q2 | -1.04 Million AUD | 0.0% |
| 2018 Q4 | -1.11 Million AUD | 0.0% |
| 2018 FY | - AUD | -3.68% |
| 2017 FY | - AUD | 14.71% |
| 2017 Q4 | -548.09 Thousand AUD | 0.0% |
| 2017 Q2 | -1.53 Million AUD | 0.0% |
| 2016 Q1 | -69.53 Thousand AUD | 0.0% |
| 2016 Q3 | -611.49 Thousand AUD | 32.67% |
| 2016 Q2 | -908.24 Thousand AUD | -1206.1% |
| 2016 FY | - AUD | -524.13% |
| 2016 Q4 | -534.83 Thousand AUD | 12.54% |
| 2015 Q3 | -69.53 Thousand AUD | 0.0% |
| 2015 Q1 | -68.02 Thousand AUD | 0.0% |
| 2015 Q4 | -69.53 Thousand AUD | 0.0% |
| 2015 Q2 | -69.53 Thousand AUD | -2.22% |
| 2015 FY | - AUD | -51.69% |
| 2014 Q3 | -68.02 Thousand AUD | 0.0% |
| 2014 FY | - AUD | 86.27% |
| 2014 Q2 | -68.02 Thousand AUD | 85.54% |
| 2014 Q1 | -470.37 Thousand AUD | 0.0% |
| 2014 Q4 | -68.02 Thousand AUD | 0.0% |
| 2013 Q4 | -470.37 Thousand AUD | 0.0% |
| 2013 FY | - AUD | 38.67% |
| 2013 Q1 | -766.98 Thousand AUD | 0.0% |
| 2013 Q2 | -470.37 Thousand AUD | 38.67% |
| 2013 Q3 | -470.37 Thousand AUD | 0.0% |
| 2012 Q4 | -766.98 Thousand AUD | 0.0% |
| 2012 Q2 | -766.98 Thousand AUD | 0.0% |
| 2012 Q3 | -766.98 Thousand AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Artrya Limited | -13.95 Million AUD | 67.782% |
| Beamtree Holdings Limited | -331 Thousand AUD | -1258.308% |
| Cogstate Limited | 9.89 Million AUD | 145.454% |
| Careteq Limited | -826.61 Thousand AUD | -443.904% |
| Doctor Care Anywhere Group PLC | -8.35 Million AUD | 46.181% |
| Emyria Limited | -13.03 Million AUD | 65.508% |
| Global Health Limited | -1.76 Million AUD | -154.619% |
| HITIQ Limited | -2.54 Million AUD | -76.825% |
| Intelicare Holdings Limited | -3.02 Million AUD | -48.849% |
| ImExHS Limited | -1.25 Million AUD | -257.472% |
| Mach7 Technologies Limited | -2.44 Million AUD | -84.108% |
| MedAdvisor Limited | 7.04 Million AUD | 163.788% |
| Oakridge International Limited | -630.05 Thousand AUD | -613.591% |
| Opyl Limited | -3.2 Million AUD | -40.095% |
| PainChek Limited | -9.48 Million AUD | 52.616% |
| Pro Medicus Limited | 120.76 Million AUD | 103.723% |
| Resonance Health Limited | -457 Thousand AUD | -883.79% |
| Singular Health Group Ltd | -2.88 Million AUD | -55.833% |
| Total Brain Limited | -5.49 Million AUD | 18.122% |